Dohj LLC grew its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 180.0% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,810 shares of the conglomerate's stock after acquiring an additional 3,092 shares during the period. Dohj LLC's holdings in Danaher were worth $986,000 at the end of the most recent reporting period.
Several other institutional investors have also modified their holdings of the company. Kentucky Retirement Systems Insurance Trust Fund increased its position in shares of Danaher by 11.6% in the fourth quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock valued at $4,874,000 after buying an additional 2,202 shares in the last quarter. FAS Wealth Partners Inc. increased its holdings in Danaher by 20.6% during the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after acquiring an additional 1,639 shares in the last quarter. ICICI Prudential Asset Management Co Ltd acquired a new position in Danaher during the fourth quarter worth about $4,591,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of Danaher by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate's stock valued at $933,524,000 after purchasing an additional 135,047 shares in the last quarter. Finally, CIBC Asset Management Inc grew its position in shares of Danaher by 24.4% in the fourth quarter. CIBC Asset Management Inc now owns 254,327 shares of the conglomerate's stock valued at $58,308,000 after purchasing an additional 49,964 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.
Analysts Set New Price Targets
DHR has been the subject of several research reports. Bank of America cut their price objective on Danaher from $265.00 to $230.00 in a research report on Monday, April 14th. Citigroup restated a "buy" rating on shares of Danaher in a report on Monday, April 7th. Robert W. Baird dropped their target price on Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Evercore ISI lowered their target price on shares of Danaher from $240.00 to $230.00 and set an "outperform" rating for the company in a report on Tuesday, April 22nd. Finally, Barclays increased their price target on shares of Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 22nd. Five investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $248.17.
Check Out Our Latest Report on Danaher
Danaher Stock Performance
DHR stock traded down $1.07 on Monday, reaching $199.60. The company's stock had a trading volume of 908,568 shares, compared to its average volume of 4,261,658. The firm has a fifty day moving average of $192.80 and a two-hundred day moving average of $210.81. The company has a market capitalization of $142.85 billion, a P/E ratio of 37.81, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a 52 week low of $171.00 and a 52 week high of $281.70.
Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, analysts predict that Danaher Co. will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.64%. Danaher's dividend payout ratio is 24.85%.
Insider Buying and Selling
In related news, EVP Christopher Paul Riley sold 15,805 shares of Danaher stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares of the company's stock, valued at $611,036,665.92. This represents a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is currently owned by corporate insiders.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
